Models of estrogen receptor–positive breast cancer are used to explore the rationale for androgen receptor agonists as treatments for breast cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hickey, T.E. et al. Nat. Med. https://doi.org/10.1038/s41591-020-01168-7 (2020).
Adair, F. E. & Herrmann, J. B. Ann. Surg. 123, 1023–1035 (1946).
Kelley, R. M. Cancer 28, 1686–1691 (1971).
Hu, R. et al. Clin. Cancer Res. 17, 1867–1874 (2011).
Vera-Badillo, F. E. et al. J. Natl. Cancer Inst. 106, djt319 (2014).
Palmieri, C. et al. San Antonio Breast Cancer Symposium https://www.abstractsonline.com/pp8/#!/9223/presentation/850 (2020).
Michmerhuizen, A. R., Spratt, D. E., Pierce, L. J. & Speers, C. W. NPJ Breast Cancer 6, 47 (2020).
Krop, I. et al. Clin. Cancer Res. 26, 6149–6157 (2020).
Garay, J. P. & Park, B. H. Am. J. Cancer Res. 2, 434–445 (2012).
D’Amato, N. C. et al. Mol. Cancer Res. 14, 1054–1067 (2016).
Schiff, R., Massarweh, S., Shou, J. & Osborne, C. K. Clin. Cancer Res. 9, 447S–454S (2003).
Arruabarrena-Aristorena, A. et al. Cancer Cell (2020).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
C.C. has performed advisory board and/or consulting work for Genentech, GRAIL, Illumina and NanoString, and reports GRAIL stockholdings.
Rights and permissions
About this article
Cite this article
Caswell-Jin, J.L., Curtis, C. Androgen receptor agonists as breast cancer therapeutics. Nat Med 27, 198–199 (2021). https://doi.org/10.1038/s41591-021-01242-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01242-8
This article is cited by
-
Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer
British Journal of Cancer (2021)
-
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
Nature Reviews Immunology (2021)